Lexaria Bioscience Corp. Discusses $11 Million Public Offering and 2021 Goals with The Stock Day Podcast

Jan 28, 01:40 PM
READ FULL PRESS RELEASE: https://stockdaymedia.com/lexaria-bioscience-corp-discusses-11-million-public-offering-and-2021-goals-with-the-stock-day-podcast-lexx-january-18-2021/

The Stock Day Podcast welcomed Lexaria Bioscience Corp. (Nasdaq:LEXX) (CSE:LXX) (“the Company”), a company with the proprietary drug delivery technology, DehydraTECH™, which improves the way active pharmaceutical ingredients (APIs) enter the bloodstream. CEO of the Company, Chris Bunka, joined Stock Day host Everett Jolly.